Skip to Main Content

Author Details

Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
2004
69
19
PMIDPaper TitleJournal TitlePublished Year
36043552Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.Cancer Med2023
37271257RARRES2 is Downregulated in Isocitrate Dehydrogenase 1 Mutant Glioma Patients and Served as an Unfavorable Prognostic Factor of Glioma.World Neurosurg2023
35937942CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.Dis Markers2022
35764946Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.BMC Pediatr2022
35624190PBX1, EMCN and ERG are associated with the sub-clusters and the prognosis of VHL mutant clear cell renal cell carcinoma.Sci Rep2022
35655142TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma.BMC Genom Data2022
34335936Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma.J Cancer2021
33878963A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.Sci Prog2021
34734491Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma.Cancer Med2021
33959491Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of <i>SPATS2L</i> in Patients With Glioma.Front Oncol2021
34116676Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma.BMC Pediatr2021
34088969RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.Sci Rep2021
32323836Integrated analysis of the E2F transcription factors across cancer types.Oncol Rep2020
32638267High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.Purinergic Signal2020
32593299Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets.BMC Pediatr2020
32950968Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer.Aging (Albany NY)2020
32328202Prognostic significance of age related genes in patients with lower grade glioma.J Cancer2020
30675196Tumor immunohistochemistry and preoperative magnetic resonance imaging features predict local recurrence of giant cell tumor of bone following intralesional curettage.Oncol Lett2019
31596728A molecular sub-cluster of colon cancer cells with low VDR expression is sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment.Aging (Albany NY)2019
31420604Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer.Oncogene2019
31592194KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα.Cancer Cell Int2019
31221124Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.BMC Cancer2019
29239274Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.J Int Med Res2018
30552662BRD4 interacts with PML/RARα in acute promyelocytic leukemia.Front Med2018
29600575Matrix metalloproteinase-9 expression of GCTSC in peripheral tissue and central tissue of GCTB.J Cell Biochem2018
28063140Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells.Front Med2017
28365887Erratum to: A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.Radiol Med2017
28271361Prognosis of local recurrence in giant cell tumour of bone: what can we do?Radiol Med2017
28271359A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.Radiol Med2017
29255669Retrospective investigation of "paint brush borders" sign in association with local recurrence of giant cell tumor of bone after intralesional curettage.J Bone Oncol2017
27605212Activation of <i>G0S2</i> is coordinated by recruitment of PML/RARα and C/EBPε to its promoter during ATRA-induced APL differentiation.J Leukoc Biol2017
26848620Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer.Oncotarget2016
27821288Fenretinide targets the side population in myeloma cell line NCI-H929 and potentiates the efficacy of antimyeloma with bortezomib and dexamethasone regimen.Leuk Res2016
27414678Automatic Determination of the Greulich-Pyle Bone Age as an Alternative Approach for Chinese Children with Discordant Bone Age.Horm Res Paediatr2016
27134531Maturation Disparity between Hand-Wrist Bones in a Chinese Sample of Normal Children: An Analysis Based on Automatic BoneXpert and Manual Greulich and Pyle Atlas Assessment.Korean J Radiol2016
26860129Dynamic changes in the gene expression profile during rat oral carcinogenesis induced by 4-nitroquinoline 1-oxide.Mol Med Rep2016
25390184Comparative study of Gilsanz-Ratib digital atlas and Greulich-Pyle atlas for bone age estimation in a Chinese sample.Ann Hum Biol2015
24021153Fenretinide targets chronic myeloid leukemia stem/progenitor cells by regulation of redox signaling.Antioxid Redox Signal2014
23513221Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.Proc Natl Acad Sci U S A2013
23883479Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide.Exp Biol Med (Maywood)2013
23547873Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.J Hematol Oncol2013
21993313Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.Leuk Res2012
22569057The significance of low PU.1 expression in patients with acute promyelocytic leukemia.J Hematol Oncol2012
22675550An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection.PLoS One2012
21237137Preferential involvement of both ROS and ceramide in fenretinide-induced apoptosis of HL60 rather than NB4 and U937 cells.Biochem Biophys Res Commun2011
21867633[Transcriptional regulation of BHLHB2 induced by PML-RARα].Zhongguo Shi Yan Xue Ye Xue Za Zhi2011
21931761AMD, an automated motif discovery tool using stepwise refinement of gapped consensuses.PLoS One2011
21733158An organogenesis network-based comparative transcriptome analysis for understanding early human development in vivo and in vitro.BMC Syst Biol2011
21699401A topology-preserving selection and clustering approach to multidimensional biological data.OMICS2011
21333438Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.Cancer Lett2011
  • 1 - 50 of 69

Recommended Authors

Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Nan Zhu
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Ming Zhan
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 1
Fang Zheng
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Career Start Year 2000
Number of shared co-authors 0
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0

Collaborators

Yanzhi Du
Center for Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University
Co-authored papers 19
Hai Fang
University of Bristol
Co-authored papers 12
Zhu Chen
Yong Loo Lin School of Medicine, National University of Singapore
Co-authored papers 9
Jiantao Shi
Institute of Hydrobiology, Chinese Academy of Sciences.
Co-authored papers 6
Shijun Fu
Pfizer China Inc.
Co-authored papers 2
Charles Auffray
European Institute for Systems Biology and Medicine
Co-authored papers 2
Lifu Wang
Co-authored papers 1
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers 1
Arhat Abzhanov
Imperial College London
Co-authored papers 1
Lucila Ohno-Machado
Co-authored papers 1
Keith Crawford
Co-authored papers 1
Winston Patrick Kuo
Harvard School of Dental Medicine
Co-authored papers 1
Mier Jiang
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Co-authored papers 1
Jianqin Zhou
Zibo Central Hospital
Co-authored papers 1
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 1
Haiguang Zhao
Hua Dong Hospital Affiliated to Fu Dan University.
Co-authored papers 1
Jason Gang Jin
ShanghaiBio Corporation
Co-authored papers 1
Release 1.2